Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

;Total;Units;P.A.;Higher Education;PNPI;
Units that perform R+D in Biotechnology;1.328;1.133;123;64;8;
%Units according to biotechnology used: Genetic code;40;32;90;89;63;
%Units according to biotechnology used: Functional units;48;41;87;95;25;
%Units according to biotechnology used: Cellular and tissue culturing and engineering;34;27;74;84;63;
%Units according to biotechnology used: Bioprocesses;51;48;56;92;50;
%Units according to biotechnology used: Sub-cellular organisms;16;8;53;72;25;
%Units according to biotechnology used: Bio-computing;29;21;70;86;25;
%Units according to biotechnology used: Nanobiotechnology;20;14;45;73;13;
%Units according to biotechnology used: Other;13;13;11;13;13;
Units in which biotechnology activities are:  Main and/or exclusive;608;564;36;3;5;
Units in which biotechnology activities are: A secondary line of business;294;212;37;43;2;
Units in which biotechnology activities are: A tool necessary for production;427;358;50;18;1;
%Units by field(s) of ultimate application of biotechnology use: Human health;55;50;77;92;75;
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;21;19;19;59;13;
%Units by field(s) of ultimate application of biotechnology use: Food products;31;29;20;86;13;
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;24;21;20;72;25;
%Units by field(s) of ultimate application of biotechnology use: Environment;17;13;23;73;25;
%Units by field(s) of ultimate application of biotechnology use: Industry;16;13;12;70;25;
Personnel in R&D in biotechnology (no. of persons);35.705;10.706;12.279;12.405;315;
Personnel in R&D in biotechnology (no. of persons): Researchers;23.534;6.227;7.396;9.662;249;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;12.171;4.479;4.883;2.743;66;
Personnel in R&D in biotechnology (no. of persons): women;19.535;5.795;7.333;6.213;194;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;12.149;3.269;4.137;4.591;152;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;7.387;2.527;3.196;1.622;42;
Personnel in R&D in biotechnology (FTE);24.830,2;7.716,4;9.470,2;7.544,3;99,3;
Personnel in R&D in biotechnology (FTE): Researchers;15.765,2;4.603,1;5.358,9;5.744,2;59;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;9.065;3.113,3;4.111,3;1.800,1;40,3;
Personnel in R&D in biotechnology (FTE): women;14.026,5;4.292,9;5.768,1;3.898,4;67,1;
Personnel in R&D in biotechnology (FTE): (women) Researchers;8.366,6;2.446,4;3.075,3;2.804,9;40;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;5.659,9;1.846,5;2.692,8;1.093,5;27,1;
Internal expenditure on R&D (thousands of euros);1.579.928;616.053;578.188;380.311;5.376;
1) By nature of the expense: Current expenses;1.488.894;574.245;551.435;358.168;5.046;
1.1) Remuneration to researchers;639.606;221.741;207.123;208.812;1.930;
1.2) Remuneration to technicians and assistants;273.257;102.464;114.013;56.002;779;
1.3) Other current expenses;576.031;250.041;230.300;93.354;2.337;
2) By nature of the expense: Capital expenses;91.034;41.808;26.752;22.144;330;
2.1) Land and buildings;15.476;5.359;4.304;5.813;.;
2.2) Equipment and instruments;66.410;29.489;21.427;15.163;330;
2.3) Acquisition of specific R+D software;4.363;2.306;956;1.102;.;
2.4) Otros productos de propiedad intelectual específicos para I+D;4.785;4.654;65;66;.;
1) By origin of the funds: National funds;1.383.507;511.960;533.002;333.525;5.020;
1.1) Own funds;510.526;382.335;66.621;60.810;761;
1.2) From companies;119.013;45.024;42.520;29.798;1.672;
1.3) Public Administration funds;702.795;72.387;393.166;236.358;884;
1.4) From Universities;2.790;363;2.018;308;100;
1.5) From non profit private institutions;48.382;11.851;28.676;6.251;1.603;
1) By origin of the funds: Foreign funds;196.421;104.093;45.186;46.786;356;
2.1) From EU programmes;101.384;21.825;39.684;39.875;.;
2.2) Other foreign funds;95.037;82.269;5.501;6.911;356;
Purchase of services R & D in Biotechnology to (thousands of euros);167.608;144.342;20.609;2.618;38;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;92.199;70.458;19.167;2.536;38;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;75.409;73.885;1.442;82;.;
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;49;48;56;53;75;
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;12;13;7;9;0;
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;18;15;39;36;25;
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;15;12;26;27;38;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;18;16;31;41;25;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;19;16;34;36;38;
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;15;16;12;14;38;
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;36;36;35;27;50;
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;49;49;50;55;50;
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;18;18;20;14;38;
%Units that have requested biotechnology patents in Biotechnology;21;16;45;73;.;
Number of patents requested;1.809;633;690;486;.;
Notas:

.
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute